By measuring extracellular cholesterol concentrations, we observed that activating PERK via CCT020312 markedly increased cholesterol efflux from glioma cells into the culture medium, whereas blocking PERK through ISRIB considerably decreased cholesterol secretion (Figure 7F,G). The gene discussed is EIF2AK3; the disease is glioma.